Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

EP27: Blood Sugar And Testing - Summary

Dr. Warwick Bishop is a practicing cardiologist and author dedicated to educating patients about heart health and cardiovascular care. In this episode, he discusses a patient case involving blood sugar assessment and explores the limitations of standard glucose tolerance testing. Dr. Bishop explains why measuring insulin resistance through the HOMA index may be a more effective diagnostic approach for identifying cardiovascular risk factors in certain patients.

Key Takeaways:

• Standard glucose tolerance tests may miss insulin resistance because they only measure blood sugar at fasting and two hours post-glucose load, missing the metabolic activity that occurs in between.

• A patient can have a "normal" glucose tolerance test result while still showing signs of insulin resistance, including elevated fasting glucose, elevated triglycerides, low HDL cholesterol, and central weight gain.

• The HOMA (Homeostatic Metabolic Assessment) index uses simultaneous fasting blood sugar and insulin measurements to calculate an index that indicates whether a patient is insulin resistant.

• High HOMA index values (elevated insulin with slightly elevated or normal blood sugar) indicate insulin resistance, meaning the body requires excessive insulin to control blood sugar levels.

• Insulin resistance is strongly linked to cardiovascular risk factors including elevated triglycerides, reduced HDL cholesterol, and central obesity.

• Patients with insulin resistance benefit significantly from reducing carbohydrate consumption, which can lower insulin response, promote weight loss, reduce triglycerides, and improve HDL levels.

• HOMA testing may be a more appropriate initial assessment than glucose tolerance testing for patients showing metabolic syndrome characteristics, even if their fasting glucose isn't high enough to indicate diabetes.